Registration and Housing
Deadlines Sept. 19
Discounted registration for the 23rd Annual Meeting and Associated Programs ends September 19. To reserve your spot (and your discount!) for the programs, register now!
Hotel rooms at the conference hotel are filling quickly. Click here to make your reservation at the conference rate of $225/night for a single king room and $245/night for a double room. This discounted rate will only be available until September 19 or until the iSBTc room block reaches capacity.
Late-Breaking Abstract
Submissions Due Sept. 19
Late-breaking abstract submissions are being accepted in conjunction with the 23rd Annual Meeting until September 19.
For more details or to submit an abstract, click here or visit the iSBTc website.
Late-breaking abstract submission offers:
- Your complete abstract printed in the iSBTc Poster Abstract Book
- Opportunity to present a poster at the iSBTc Annual Meeting
- Opportunity to feature your research and network with colleagues
Don't delay; submit your late-breaking abstract today!
Program Highlights
Global Regulatory Summit on Oncology Biologics Development
October 29, 2008 - San Diego, CA
Brings together leaders from world-wide regulatory agencies to give perspective and facilitate discussion on regulatory considerations in the development of oncology biologics products.
Countries Presenting:
USA, Canada, Europe, Japan, India, Switzerland, China
Summit Goals:
- Discuss world-wide regulatory oversight including differences/similarities in regulatory approach
- Discuss global regulatory considerations for product pre-clinical and clinical studies and clinical trial design/analysis issues
- Establish dialogue between academia, regulatory bodies and industry regarding global implications and future direction of oncology biologics development
For more information, click here.
Hot Topic Symposium on Anti-CTLA-4
November 2, 2008 - San Diego, CA
iSBTc will host a symposium featuring invited speakers, panel discussion/debate and audience questions regarding "Anti-CTLA-4: Issues in Development and Regulatory Approval."
Plans for the symposium include:
- Summarizing current results of clinical developments of anti-CTLA-4 antibodies
- Understanding the complexity of regulatory issues and definition of outcome measures in cancer clinical trials utilizing biologicals
- Improving the design and implementation of attendees' research-aimed preclinical or clinical development of immunological agents and biomarkers
There is no fee to attend this session, but registration is required.
Workshop on Cancer and Inflammation
October 30, 2008 - San Diego, CA
Small group, interactive workshop assembles thought-leaders in the field of cancer biologics to discuss inflammation and its role in cancer with an expected results publication following the program.
Workshop Goals:
- Discuss the most recent updates on advances involving pro and anti-inflammatory agents
- Clarify the relationship between chronic inflammation and cancer, promoting possible biologic therapies in combination with other agents
- Discuss regulatory and legal issues surrounding cancer clinical trials involving pro and anti-inflammatory agents
For more information, click here.
Primer on Tumor Immunology and Biological Therapy
October 30, 2008 - San Diego, CA
Experts provide a current overview of immunology as it applies to cancer etiology, biology and therapy. Reviews current status and recent advances in:
- Cancer vaccines
- Host-tumor interactions
- Vaccine adjuvants
- Role of innate/adaptive immune systems
For more information, click here.
23rd Annual Meeting
October 31 – November 2, 2008 – San Diego, CA
Gathers the leading experts in immunotherapy/biological therapy of cancer from all venues for education and exchange of cutting edge preclinical and clinical data between basic scientists and clinicians.
Discussion on:
- Advances in cancer biology, intersection with the immune system, and relevance for biologic cancer therapy
- Clinical/translational work in cancer immunotherapy
- Collaborations among constituents to result in more efficient trials
- Options in trial design including immune monitoring techniques and compliance with regulatory guidelines.
- Resources available through government agencies which facilitate translational research
For more information, click here.
Exhibit Space Available - due Sept 12
iSBTc is accepting applications for exhibitors for the 23rd Annual Meeting until September 12! If you know a company that should have a presence in the iSBTc Exhibit Hall, please click here for additional information or contact the iSBTc office at 414-271-2456 (info@isbtc.org).
Pharmaceutical and biotech companies, medical publishers, suppliers, device companies, and research/regulatory consultants and agencies are invited to participate.